Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis - the IDIRA study.

Kvasnićka J, Sulková S, Svára F, Polakovic, Iron supplementation during erythropoietin therapy in patients on hemodialysis Vnitr̆ní lékar̆ství. ,vol. 42, pp. 849- 852 ,(1996)

Francesco Locatelli, Pedro Aljama, Peter Bárány, Bernard Canaud, Fernando Carrera, Kai-Uwe Eckardt, Walter H Hörl, Iain C Macdougal, Alison Macleod, Andrzej Wiecek, Stewart Cameron, European Best Practice Guidelines Working Group, Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation. ,vol. 19, pp. 1- 47 ,(2004) , 10.1093/NDT/GFH1032

Ajay Gupta, Susan E. Vogel, Stanley Frinak, Anatole Besarab, Gary Zazuwa, J. V. Anandan, Neeta Amin, James J. Zazra, Muhammad Ahsan, Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients Journal of The American Society of Nephrology. ,vol. 11, pp. 530- 538 ,(2000) , 10.1681/ASN.V113530

James T. McCarthy, Cynthia E. Regnier, Carrie L. Loebertmann, Erik J. Bergstralh, Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products. American Journal of Nephrology. ,vol. 20, pp. 455- 462 ,(2000) , 10.1159/000046199

S. Anuradha, N. P. Singh, S. K. Agarwal, TOTAL DOSE INFUSION IRON DEXTRAN THERAPY IN PREDIALYSIS CHRONIC RENAL FAILURE PATIENTS Renal Failure. ,vol. 24, pp. 307- 313 ,(2002) , 10.1081/JDI-120005364

Jorge Silva, Sequeira Andrade, Humberto Ventura, JP Santos, Suzana Colaço, Carlos Oliveira, Pedro Ponce, Iron supplementation in haemodialysis--practical clinical guidelines. Nephrology Dialysis Transplantation. ,vol. 13, pp. 2572- 2577 ,(1998) , 10.1093/NDT/13.10.2572

Denise J. Roe, Antonia M. Harford, Philip G. Zager, Thomas B. Wiltbank, Linda Kirlin, Ann Marie Della Valle, David B. Van Wyck, Iron Utilization After Iron Dextran Administration for Iron Deficiency in Patients With Dialysis-Associated Anemia: A Prospective Analysis and Comparison of Two Agents American Journal of Kidney Diseases. ,vol. 28, pp. 855- 860 ,(1996) , 10.1016/S0272-6386(96)90385-6

Steven Fishbane, Gill L. Frei, John Maesaka, Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. American Journal of Kidney Diseases. ,vol. 26, pp. 41- 46 ,(1995) , 10.1016/0272-6386(95)90151-5

Akihiko Kato, Mayumi Hamada, Takayuki Suzuki, Takanori Maruyama, Yukitaka Maruyama, Akira Hishida, Effect of Weekly or Successive Iron Supplementation on Erythropoietin Doses in Patients Receiving Hemodialysis Nephron. ,vol. 89, pp. 110- 112 ,(2001) , 10.1159/000046053

Luis Bolaños, Pedro Castro, Teresa G. Falcón, Ricardo Mouzo, José Manuel Varela, Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients. American Journal of Nephrology. ,vol. 22, pp. 67- 72 ,(2002) , 10.1159/000046676